What ibogaine is, and why researchers are studying it
Ibogaine is an alkaloid found in the root bark of Tabernanthe iboga, a shrub native to West and Central Africa, where iboga has been used ceremonially for generations. Pharmacologically it is unlike any approved psychiatric medicine: rather than modulating a single neurotransmitter system day after day, a single supervised session appears to trigger a period of heightened neuroplasticity. This page explains the proposed mechanisms in plain language, what conditions ibogaine is being investigated for, and — just as importantly — the cardiac and other risks that make unsupervised use dangerous. Nothing on this page is medical advice.
Last reviewed:
Ibogaine: A Catalyst for Genuine Neurological Repair
Why Ibogaine Is Different: Ibogaine is not a recreational psychedelic. It is an oneirogen — a dream-state compound derived from the West African Tabernanthe iboga shrub that triggers deep neurological repair mechanisms unavailable to any other known substance or therapy.
The Stanford MISTIC study demonstrated dramatic symptom reduction in PTSD and TBI in as few as one to two sessions — results unmatched in conventional psychiatric literature.
GDNF Release
Triggers Glial Cell-Derived Neurotrophic Factor, physically repairing white matter tracts and rebuilding damaged neural pathways, the biological foundation of trauma recovery.
Dopamine Reset
Resets the reward system, interrupting opioid, alcohol, and nicotine dependence and opening a critical 'biological window' for long-term sobriety.
Rapid Remission
Clinical evidence confirms significant, durable reduction of PTSD and TBI symptoms with minimal sessions reducing patient burden and system cost.
Repairing the Brain from the Inside Out
Ibogaine's mechanism is fundamentally distinct from any approved psychiatric medication. By acting directly on the neurotrophin pathway, it addresses the biological substrate of trauma, not merely its symptoms. Where SSRIs modulate mood, ibogaine rebuilds the architecture of the mind.
For PTSD
Disrupts the hyperactive fear-memory consolidation cycle, enabling patients to process trauma without re-traumatisation.
For TBI
Promotes axonal regeneration and myelin repair via GDNF, restoring cognitive function lost to blast injury and concussive trauma.
For Addiction
Eliminates acute withdrawal and resets craving pathways, providing a clean neurological slate for sustained recovery programmes.
Help make ibogaine therapy available in Israel
Add your name to the public petition, or contact us about research collaboration, clinical partnership, volunteering, or media enquiries. We reply to every message.